| Autor: |
Roberto Giugliani, Sandra Marques, Luis G. M. de Andrade, André Pessoa, Maria H. Vaisbich, Angélica Blum, Fernanda Tenório, Nilton S Rosa Neto |
| Jazyk: |
angličtina |
| Rok vydání: |
2022 |
| Předmět: |
|
| Zdroj: |
Journal of Inborn Errors of Metabolism and Screening, Vol 10 (2022) |
| Druh dokumentu: |
article |
| ISSN: |
2326-4594 |
| DOI: |
10.1590/2326-4594-jiems-2021-0028 |
| Popis: |
ABSTRACT Research on the genetics, epidemiology, and clinical manifestations of Fabry disease (FD) has increased significantly in recent years. However, some relevant clinical questions still need to be answered to develop better approaches to patient management. This review focuses on answering specific questions raised by Brazilian experts based on their experience in diagnosing and managing patients with FD. The questions are as follows: What is the role of globotriaosylsphingosine in diagnosis? How does one proceed with the diagnosis if there is a variant of unknown significance? What are the earliest and most reliable markers of renal, cardiac, and neurological impairment? What is the prevalence of FD in patients with cryptogenic stroke? What is the average delay in diagnosis in patients with FD? Based on these questions, our objective was to highlight epidemiological, diagnostic, and clinical aspects relating to the literature in the FD field. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
